• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance.新发真菌感染:新物种、新名称和抗真菌耐药性。
Clin Chem. 2021 Dec 30;68(1):83-90. doi: 10.1093/clinchem/hvab217.
2
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.人类致病酵母和丝状真菌的耐药性:流行情况、潜在分子机制以及与人类和环境中抗真菌药物使用的关联
Dan Med J. 2016 Oct;63(10).
3
Emerging moulds: epidemiological trends and antifungal resistance.新兴霉菌:流行病学趋势和抗真菌耐药性。
Mycoses. 2011 Nov;54(6):e666-78. doi: 10.1111/j.1439-0507.2011.02032.x. Epub 2011 Jun 14.
4
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.罕见及新出现的机会性真菌病原体:对白色念珠菌和烟曲霉之外的耐药性的关注。
J Clin Microbiol. 2004 Oct;42(10):4419-31. doi: 10.1128/JCM.42.10.4419-4431.2004.
5
Current status of antifungal resistance and its impact on clinical practice.抗真菌药物耐药现状及其对临床实践的影响。
Br J Haematol. 2014 Aug;166(4):471-84. doi: 10.1111/bjh.12896. Epub 2014 Apr 18.
6
Emerging and less common fungal pathogens.新出现的和较少见的真菌病原体。
Infect Dis Clin North Am. 2002 Dec;16(4):915-33, vi-vii. doi: 10.1016/s0891-5520(02)00041-7.
7
Antifungal resistance in superficial mycoses.浅部真菌感染中的抗真菌耐药性。
J Dermatolog Treat. 2022 Jun;33(4):1888-1895. doi: 10.1080/09546634.2021.1942421. Epub 2021 Jun 30.
8
New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species.涉及耐药非白念珠菌物种的新发感染的新型和有前途的化疗药物。
Curr Top Med Chem. 2019;19(28):2527-2553. doi: 10.2174/1568026619666191025152412.
9
Emerging and re-emerging fungal threats in Africa.非洲新出现和再现的真菌威胁。
Parasite Immunol. 2023 Feb;45(2):e12953. doi: 10.1111/pim.12953. Epub 2022 Oct 17.
10
Meeting the challenge of invasive fungal infections: part 1.应对侵袭性真菌感染的挑战:第 1 部分。
Future Microbiol. 2013 Sep;8(9):1063-5. doi: 10.2217/fmb.13.96.

引用本文的文献

1
Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B.Etest、MICRONAUT-AM EUCAST与基于参考肉汤微量稀释法的CLSI抗真菌药敏试验结果的直接比较:对两性霉素B敏感性降低检测的意义
J Fungi (Basel). 2025 Jul 30;11(8):570. doi: 10.3390/jof11080570.
2
New insights on Drug's design against candidiasis on the fructose biphosphate aldolase (Fba1) and the pyruvate kinase (Pk) of .关于针对念珠菌病设计的药物对果糖二磷酸醛缩酶(Fba1)和丙酮酸激酶(Pk)的新见解。
Biochem Biophys Rep. 2025 Jul 25;43:102175. doi: 10.1016/j.bbrep.2025.102175. eCollection 2025 Sep.
3
Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020-2024.2020 - 2024年巴基斯坦儿科患者中的斯帕蒂纳舍弗酵母血症
Emerg Infect Dis. 2025 Aug;31(8):1550-1560. doi: 10.3201/eid3108.241604.
4
The Antidepressant Sertraline Modulates Gene Expression and Alternative Splicing Events in the Dermatophyte : A Comprehensive Analysis.抗抑郁药舍曲林调节皮肤癣菌中的基因表达和可变剪接事件:一项综合分析。
Genes (Basel). 2025 Jan 24;16(2):146. doi: 10.3390/genes16020146.
5
Occurrence of Pathogenic and Allergenic Molds in the Outdoor and Indoor Environment of a Major Hospital and Molecular Epidemiology of in Kuwait.科威特一家大型医院室外和室内环境中致病性和致敏性霉菌的发生情况及分子流行病学研究
J Fungi (Basel). 2025 Jan 21;11(2):83. doi: 10.3390/jof11020083.
6
Synthesis, Biological Properties, In Silico ADME, Molecular Docking Studies, and FMO Analysis of Chalcone Derivatives as Promising Antioxidant and Antimicrobial Agents.查尔酮衍生物作为有前景的抗氧化剂和抗菌剂的合成、生物学性质、计算机辅助药物代谢动力学、分子对接研究及黄素单加氧酶分析
ACS Omega. 2025 Jan 28;10(5):4367-4387. doi: 10.1021/acsomega.4c06897. eCollection 2025 Feb 11.
7
Establishment of a Mouse Intravenous Challenge Model for Predicting Virulence in Yarrowia lipolytica Disseminated Infection.建立用于预测解脂耶氏酵母播散性感染毒力的小鼠静脉内攻击模型。
Mycopathologia. 2025 Feb 1;190(1):21. doi: 10.1007/s11046-025-00930-0.
8
Genome-Wide Exploration of Thiamin Pyrophosphate Riboswitches in Medically Relevant Fungi Reveals Diverse Distribution and Implications for Antimicrobial Drug Targeting.医学相关真菌中硫胺素焦磷酸核糖开关的全基因组探索揭示了其多样分布及对抗菌药物靶向的意义。
ACS Omega. 2024 Dec 10;9(51):50134-50146. doi: 10.1021/acsomega.4c00158. eCollection 2024 Dec 24.
9
Biological and genomic analyses of , a novel potential fungal pathogen closely related to (syn. ) and .对一种与……(同义词……)和……密切相关的新型潜在真菌病原体进行生物学和基因组分析。 (注:原文中“Biological and genomic analyses of ”这里的“of ”后面缺少具体内容)
New Microbes New Infect. 2024 Oct 10;62:101506. doi: 10.1016/j.nmni.2024.101506. eCollection 2024 Dec.
10
Affinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a.基于几丁质亲和性和 RPA-CRISPR/Cas12a 的检测白色念珠菌的亲和力分子检测法
Nat Commun. 2024 Oct 28;15(1):9304. doi: 10.1038/s41467-024-53693-5.

本文引用的文献

1
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?新型冠状病毒肺炎相关肺曲霉病(CAPA):它是一个多大的问题?
Clin Microbiol Infect. 2021 Sep;27(9):1376-1378. doi: 10.1016/j.cmi.2021.06.025. Epub 2021 Jun 27.
2
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
3
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征:印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
4
COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion.COVID-19 相关曲霉菌气管支气管炎:病毒嗜性、宿主防御和真菌感染之间的相互作用。
Lancet Respir Med. 2021 Jul;9(7):795-802. doi: 10.1016/S2213-2600(21)00138-7. Epub 2021 May 26.
5
Emerging Fungal Infections.新发真菌感染。
Infect Dis Clin North Am. 2021 Jun;35(2):261-277. doi: 10.1016/j.idc.2021.03.014.
6
Recent Trends in the Epidemiology of Fungal Infections.真菌感染流行病学的最新趋势。
Infect Dis Clin North Am. 2021 Jun;35(2):237-260. doi: 10.1016/j.idc.2021.03.001.
7
: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities.流行病学、诊断、发病机制、抗真菌药敏性以及控制医疗机构感染传播的感染控制措施。
Microorganisms. 2021 Apr 11;9(4):807. doi: 10.3390/microorganisms9040807.
8
Taxonomy of the Trichophyton mentagrophytes/T. interdigitale Species Complex Harboring the Highly Virulent, Multiresistant Genotype T. indotineae.地霉属毛癣菌/须癣毛癣菌复合种中携带高度致病、多耐药基因型 T. indotineae 的分类学研究。
Mycopathologia. 2021 Jun;186(3):315-326. doi: 10.1007/s11046-021-00544-2. Epub 2021 Apr 13.
9
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.应对 COVID-19 相关曲霉病的不确定性:与流感相关曲霉病的比较。
J Infect Dis. 2021 Nov 22;224(10):1631-1640. doi: 10.1093/infdis/jiab163.
10
COVID-19 and orbital mucormycosis.新型冠状病毒肺炎与眼眶毛霉菌病
Indian J Ophthalmol. 2021 Apr;69(4):1002-1004. doi: 10.4103/ijo.IJO_3763_20.

新发真菌感染:新物种、新名称和抗真菌耐药性。

Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance.

机构信息

Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

出版信息

Clin Chem. 2021 Dec 30;68(1):83-90. doi: 10.1093/clinchem/hvab217.

DOI:10.1093/clinchem/hvab217
PMID:34969112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9383166/
Abstract

BACKGROUND

Infections caused by fungi can be important causes of morbidity and mortality in certain patient populations, including those who are highly immunocompromised or critically ill. Invasive mycoses can be caused by well-known species, as well as emerging pathogens, including those that are resistant to clinically available antifungals.

CONTENT

This review highlights emerging fungal infections, including newly described species, such as Candida auris, and those that having undergone taxonomic classification and were previously known by other names, including Blastomyces and Emergomyces species, members of the Rasamsonia argillacea species complex, Sporothrix brasiliensis, and Trichophyton indotinae. Antifungal resistance also is highlighted in several of these emerging species, as well as in the well-known opportunistic pathogen Aspergillus fumigatus. Finally, the increased recognition and importance of fungal co-infections with respiratory pathogens, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is discussed.

SUMMARY

Both clinicians and clinical microbiology laboratories should remain vigilant regarding emerging fungal infections. These may be difficult both to diagnose and treat due to the lack of experience of clinicians and laboratory personnel with these organisms and the infections they may cause. Many of these fungal infections have been associated with poor clinical outcomes, either due to inappropriate therapy or the development of antifungal resistance.

摘要

背景

真菌感染可成为某些特定患者群体(包括高度免疫功能低下或病重的患者)发病和死亡的重要原因。侵袭性真菌感染可由知名菌种引起,也可由新兴病原体引起,包括对现有临床可用抗真菌药物具有耐药性的病原体。

内容

本综述重点介绍了新发真菌感染,包括新描述的菌种,如耳念珠菌,以及经过分类学分类、以前用其他名称描述的菌种,如芽生菌属和隐球菌属、泥裂丝孢菌种复合体中的 Rasamsonia argillacea 种、巴西利什曼原虫和地霉属 indotinae 种。在其中几种新发菌种中,以及在知名的机会性致病真菌烟曲霉中,也出现了抗真菌耐药性。最后,还讨论了与呼吸道病原体(包括严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2))的真菌合并感染日益受到重视的情况。

总结

临床医生和临床微生物学实验室都应持续关注新发真菌感染。由于临床医生和实验室人员对这些生物体及其可能引起的感染缺乏经验,这些感染可能难以诊断和治疗。许多这些真菌感染与不良临床结局相关,要么是由于治疗不当,要么是由于出现了抗真菌耐药性。